Press Release Tubulis
2026-04-07

Fund+ Portfolio Company Tubulis to be Acquired by Gilead

• Fund+ portfolio company Tubulis…
read more
Press Release Tubulis
2025-10-30

Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $ 401M)

New investors Fidelity Management &…
read more
Press Release Tubulis
2025-10-15

Tubulis Raises €308 Million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline

• USD 361 million round…
read more
Press Release Tubulis
2025-05-21

Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic

The program, licensed exclusively to…
read more
Press Release Tubulis
2024-06-21

Tubulis Doses First Patient in Phase I/IIa Trial Investigating ADC Candidate TUB-040 in Ovarian Cancer and Lung Adenocarcinoma

TUB-040 is a next-generation NaPi2b-targeting…
read more
Press Release Tubulis
2024-03-14

Fund+ Portfolio Company Tubulis Closes Upsized EUR 128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline

Financing round co-led by EQT…
read more
Press Release Tubulis
2023-04-20

Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients

Companies join forces bringing together…
read more
Press Release Tubulis
2022-05-03

Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies

Tubulis Closes €60 Million Series…
read more